Barb will delve into the latest findings on the newest weight loss drugs, semaglutide (Ozempic/Wegovy) and tirzepetide (Mounjaro/Zepbound)--the physiology, the pharmacology, the efficacy, and the adverse effects. She will also discuss the "something old"--including the risk/benefit of weight loss surgeries, dietary issues (protein vs carbohydrates), and yes, calories IN and calories OUT.